Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mem Inst Oswaldo Cruz ; 108(5): 623-30, 2013 08.
Artigo em Inglês | MEDLINE | ID: mdl-23903979

RESUMO

Pentavalent antimonials such as meglumine antimoniate (MA) are the primary treatments for leishmaniasis, a complex disease caused by protozoan parasites of the genus Leishmania . Despite over 70 years of clinical use, their mechanisms of action, toxicity and pharmacokinetics have not been fully elucidated. Radiotracer studies performed on animals have the potential to play a major role in pharmaceutical development. The aims of this study were to prepare an antimony radiotracer by neutron irradiation of MA and to determine the biodistribution of MA in healthy and Leishmania (Leishmania) infantum chagasi-infected mice. MA (Glucantime®) was neutron irradiated inside the IEA-R1 nuclear reactor, producing two radioisotopes, ¹²²Sb and ¹²4Sb, with high radionuclidic purity and good specific activity. This irradiated compound presented anti-leishmanial activity similar to that of non-irradiated MA in both in vitro and in vivo evaluations. In the biodistribution studies, healthy mice showed higher uptake of antimony in the liver than infected mice and elimination occurred primarily through biliary excretion, with a small proportion of the drug excreted by the kidneys. The serum kinetic curve was bi-exponential, with two compartments: the central compartment and another compartment associated with drug excretion. Radiotracers, which can be easily produced by neutron irradiation, were demonstrated to be an interesting tool for answering several questions regarding antimonial pharmacokinetics and chemotherapy.


Assuntos
Antiprotozoários/farmacocinética , Leishmania infantum , Leishmaniose , Meglumina/farmacocinética , Compostos Organometálicos/farmacocinética , Animais , Antimônio , Antiprotozoários/efeitos da radiação , Cricetinae , Feminino , Meglumina/efeitos da radiação , Antimoniato de Meglumina , Camundongos Endogâmicos BALB C , Compostos Organometálicos/efeitos da radiação , Radioisótopos , Compostos Radiofarmacêuticos , Fatores de Tempo , Distribuição Tecidual
2.
Mem. Inst. Oswaldo Cruz ; 108(5): 623-630, ago. 2013. tab, graf
Artigo em Inglês | LILACS | ID: lil-680768

RESUMO

Pentavalent antimonials such as meglumine antimoniate (MA) are the primary treatments for leishmaniasis, a complex disease caused by protozoan parasites of the genus Leishmania . Despite over 70 years of clinical use, their mechanisms of action, toxicity and pharmacokinetics have not been fully elucidated. Radiotracer studies performed on animals have the potential to play a major role in pharmaceutical development. The aims of this study were to prepare an antimony radiotracer by neutron irradiation of MA and to determine the biodistribution of MA in healthy and Leishmania (Leishmania) infantum chagasi-infected mice. MA (Glucantime(r)) was neutron irradiated inside the IEA-R1 nuclear reactor, producing two radioisotopes, 122Sb and 124Sb, with high radionuclidic purity and good specific activity. This irradiated compound presented anti-leishmanial activity similar to that of non-irradiated MA in both in vitro and in vivo evaluations. In the biodistribution studies, healthy mice showed higher uptake of antimony in the liver than infected mice and elimination occurred primarily through biliary excretion, with a small proportion of the drug excreted by the kidneys. The serum kinetic curve was bi-exponential, with two compartments: the central compartment and another compartment associated with drug excretion. Radiotracers, which can be easily produced by neutron irradiation, were demonstrated to be an interesting tool for answering several questions regarding antimonial pharmacokinetics and chemotherapy.


Assuntos
Animais , Cricetinae , Feminino , Antiprotozoários/farmacocinética , Leishmania infantum , Leishmaniose , Meglumina/farmacocinética , Compostos Organometálicos/farmacocinética , Antimônio , Antiprotozoários/efeitos da radiação , Camundongos Endogâmicos BALB C , Meglumina/efeitos da radiação , Compostos Organometálicos/efeitos da radiação , Radioisótopos , Compostos Radiofarmacêuticos , Fatores de Tempo , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA